BBIO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BridgeBio Pharma Inc

NASDAQ | BBIO

55.96

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$10.61B

Market Cap

-

P/E Ratio

-4.13

EPS

$56.24

52 Week High

$21.72

52 Week Low

HEALTHCARE

Sector

BBIO Chart

Recent Chart
Price Action

BBIO Technicals

Tags:

BBIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $218M
Total Revenue $222M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income -$593M
Selling General And Administrative $289M
Research And Development $506M
Operating Expenses $811M
Investment Income Net -
Net Interest Income -$82M
Interest Income $17M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.1M
Income Before Tax -$542M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$543M
Comprehensive Income Net Of Tax -
Ebit -$443M
Ebitda -$437M
Net Income -$536M

Revenue & Profitability

Earnings Performance

BBIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $919M
Total Current Assets $721M
Cash And Cash Equivalents At Carrying Value $681M
Cash And Short Term Investments $681M
Inventory -
Current Net Receivables $4.7M
Total Non Current Assets $199M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $24M
Intangible Assets Excluding Goodwill $24M
Goodwill -
Investments -
Long Term Investments $144M
Short Term Investments $0
Other Current Assets $35M
Other Non Current Assets -
Total Liabilities $2.4B
Total Current Liabilities $154M
Current Accounts Payable $9.6M
Deferred Revenue -
Current Debt -
Short Term Debt $4.5M
Total Non Current Liabilities $2.2B
Capital Lease Obligations $9.2M
Long Term Debt $1.7B
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.7B
Other Current Liabilities $130M
Other Non Current Liabilities $286K
Total Shareholder Equity -$1.5B
Treasury Stock -
Retained Earnings -$3.1B
Common Stock $196K
Common Stock Shares Outstanding $186M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$521M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.1M
Capital Expenditures $933K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $61M
Cashflow From Financing $748M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7.5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$543M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $218M
Total Revenue $222M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income -$593M
Selling General And Administrative $289M
Research And Development $506M
Operating Expenses $811M
Investment Income Net -
Net Interest Income -$82M
Interest Income $17M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.1M
Income Before Tax -$542M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$543M
Comprehensive Income Net Of Tax -
Ebit -$443M
Ebitda -$437M
Net Income -$536M

BBIO News

BBIO Profile

BridgeBio Pharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BridgeBio Pharma, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for genetic diseases and rare disorders. Headquartered in Palo Alto, California, BridgeBio leverages its innovative approach to drug development, employing advanced scientific methodologies to address unmet medical needs. With a robust pipeline of product candidates and a commitment to improving patient outcomes, BridgeBio is positioned as a leader in the genetic medicine landscape.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
BITF
+28.33%
$5.39
NVDA
+2.81%
$188.32
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
INTC
+2.33%
$37.22
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
GPUS
-10.39%
$0.43
CAN
+39.44%
$1.52
QBTS
+23.01%
$40.61
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.13%
$11.54
CLF
+4.93%
$13.83
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
CIFR
+19.85%
$20.34
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
NAK
+31.03%
$2.66
AMD
+0.40%
$215.76
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
RR
+8.95%
$6.45
IREN
+7.31%
$64.14
AVGO
+9.87%
$356.70
UAMY
+36.85%
$16.71
ABAT
+36.59%
$9.22
PFE
-0.20%
$24.73
SNAP
+3.47%
$8.05
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
UUUU
+16.86%
$23.77
MARA
+8.52%
$20.23
NOK
-1.31%
$5.25
EOSE
+23.37%
$17.05
BMNR
+8.34%
$56.85
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADAP
-2.59%
$0.18
EPWK
-8.00%
$0.08
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
AAPL
+0.97%
$247.66
AMZN
+1.71%
$220.07
WULF
+3.62%
$14.00
XCH
+103.41%
$1.68
T
-1.08%
$25.59
HPE
+1.63%
$24.80
RF
+1.65%
$24.56
NB
+8.95%
$11.32
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
GDXD
-13.62%
$0.73
BAC
+0.43%
$48.86
QSI
+24.55%
$2.08
KDP
+2.32%
$26.42
RGTZ
-50.00%
$9.30
VALE
+2.41%
$11.01
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
SLB
+1.73%
$32.27
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.52%
$109.91
WLGS
-5.57%
$0.04
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
TMQ
+10.62%
$6.56
GRAB
+1.19%
$5.93
KDLY
-7.21%
$0.87
GGB
+2.85%
$3.24
ETWO
0.00%
$3.30
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
BITF
+28.33%
$5.39
NVDA
+2.81%
$188.32
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
INTC
+2.33%
$37.22
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
GPUS
-10.39%
$0.43
CAN
+39.44%
$1.52
QBTS
+23.01%
$40.61
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.13%
$11.54
CLF
+4.93%
$13.83
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
CIFR
+19.85%
$20.34
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
NAK
+31.03%
$2.66
AMD
+0.40%
$215.76
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
RR
+8.95%
$6.45
IREN
+7.31%
$64.14
AVGO
+9.87%
$356.70
UAMY
+36.85%
$16.71
ABAT
+36.59%
$9.22
PFE
-0.20%
$24.73
SNAP
+3.47%
$8.05
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
UUUU
+16.86%
$23.77
MARA
+8.52%
$20.23
NOK
-1.31%
$5.25
EOSE
+23.37%
$17.05
BMNR
+8.34%
$56.85
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADAP
-2.59%
$0.18
EPWK
-8.00%
$0.08
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
AAPL
+0.97%
$247.66
AMZN
+1.71%
$220.07
WULF
+3.62%
$14.00
XCH
+103.41%
$1.68
T
-1.08%
$25.59
HPE
+1.63%
$24.80
RF
+1.65%
$24.56
NB
+8.95%
$11.32
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
GDXD
-13.62%
$0.73
BAC
+0.43%
$48.86
QSI
+24.55%
$2.08
KDP
+2.32%
$26.42
RGTZ
-50.00%
$9.30
VALE
+2.41%
$11.01
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
SLB
+1.73%
$32.27
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.52%
$109.91
WLGS
-5.57%
$0.04
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
TMQ
+10.62%
$6.56
GRAB
+1.19%
$5.93
KDLY
-7.21%
$0.87
GGB
+2.85%
$3.24
ETWO
0.00%
$3.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.